Indian pharmaceutical giant Wockhardt is currently in merger talks. The company, known for its wide range of generic and branded drugs, has been facing challenges in recent months. Sources close to the transaction suggest that Wockhardt is {attracting interest from|receiving bids from both domestic and international firms. A final decision is fores